New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - dantron 15 mg/ml; poloxamer 188 200 mg/ml - oral suspension - 15mg/ml/200mg/ml. - active: dantron 15 mg/ml poloxamer 188 200 mg/ml excipient: aluminium magnesium silicate citric acid monohydrate ethanol glycerol nipasept peach flavour 17.42.6410 propylene glycol purified water saccharin sodium sodium citrate sorbitol xanthan gum - as a lubricant, faecal softener and laxative to be administered orally for the prophylaxis and treatment of constipation in terminally ill patients of all ages.

New Zealand - English - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - dantron 15 mg/ml; poloxamer 188 200 mg/ml - oral suspension - 15/200mg/ml - active: dantron 15 mg/ml poloxamer 188 200 mg/ml excipient: aluminium magnesium silicate citric acid peach 403788 peach n30 nipasept; sodium salts of methyl, ethyl, propyl paraben potassium sorbate propylene glycol alginate purified water saccharin sodium sorbitol xanthan gum

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - dantron 15 mg/ml; poloxamer 188 200 mg/ml - oral suspension - active: dantron 15 mg/ml poloxamer 188 200 mg/ml excipient: aluminium magnesium silicate citric acid monohydrate ethanol peach ni flavour (qz04060) capsicine natural (qz01070) glyceryl mono-oleate monobasic sodium phosphate dihydrate potassium sorbate propylene glycol saccharin sodium sodium propyl hydroxybenzoate as nipasept sorbitol water

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - dantron; poloxamer 188 - oral suspension - 25mg/5ml +200 mg/5ml - contact laxatives; dantron, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd, - dantron; poloxamer 188 - oral suspension - 75mg/5ml +1000 mg/5ml - contact laxatives; dantron, combinations

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinewood healthcare - dantron; poloxamer 188 - oral suspension - 5mg/1ml ; 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinewood healthcare - poloxamer 188; dantron - oral suspension - 200mg/1ml ; 15mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - dantron 5 mg/ml; poloxamer 188 40 mg/ml - oral suspension - 5mg/ml/40mg/ml - active: dantron 5 mg/ml poloxamer 188 40 mg/ml excipient: aluminium magnesium silicate citric acid monohydrate ethanol glycerol nipasept peach flavour 17.42.6410 propylene glycol purified water saccharin sodium sodium citrate sorbitol xanthan gum - as a lubricant, faecal softener and laxative to be administered orally for the prophylaxis and treatment of constipation in terminally ill patients of all ages.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - dantron; poloxamer 188 - oral suspension - 5mg/1ml ; 40mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

approved prescription services ltd - dantron; poloxamer 188 - oral suspension - 5mg/1ml ; 40mg/1ml